According to our (Global Info Research) latest study, the global Compound Ketoconazole Cream market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Compound ketoconazole cream is a topical antifungal ointment that combines ketoconazole (a broad-spectrum antifungal ingredient) with clobetasol propionate (a potent corticosteroid). It is mainly used to treat various superficial fungal skin infections, such as tinea manuum, tinea pedis, tinea corporis, tinea cruris, pityriasis versicolor (pityriasis versicolor), and Malassezia folliculitis. It can effectively kill or inhibit fungi, while the steroid component can quickly relieve inflammatory symptoms such as itching and redness.
In 2024, the global production of compound ketoconazole cream was 68.45 million units, with an average price of US$0.77 per unit. The gross profit margin was approximately between 45% and 65%.
The upstream supply chain of compound ketoconazole cream mainly involves raw material suppliers, including ketoconazole, corticosteroids, or anti-inflammatory ingredients, as well as cream base, surfactants, stabilizers, and packaging materials. Upstream concentration is relatively high, and raw material costs are affected by fluctuations in chemical prices, environmental policies, and pharmacopoeia standards, but overall supply remains stable. The downstream supply chain is more crucial, with users including hospital dermatology departments, primary healthcare institutions, retail pharmacies, and online drug retail platforms. Compound preparations are mostly used for fungal skin diseases accompanied by inflammation, itching, or secondary infections, and their clinical use is relatively widespread, but also subject to greater regulatory scrutiny. Hospital demand is influenced by prescribing habits, availability of alternative drugs, and policy controls; retail demand depends on consumers' need for rapid symptom relief, brand awareness, and pharmacist recommendations. Because compound products can relieve inflammation and itching in the short term, consumer acceptance is high, but awareness of hormone-related risks is increasing, leading to more cautious use in some markets, requiring brands to invest more in end-user education and usage guidelines.
Future development will continue the trend of dermatological self-management and expansion of OTC channels, while also being influenced by stricter regulations and standardized medication use. Driving factors stem from the prevalence of coexisting fungal infections and skin inflammation in clinical settings, giving combination preparations the advantage of rapid symptom relief. Increased skin barrier problems in urban populations, as well as the rise in fungal infections related to hot and humid environments and sports, also drive demand. However, significant obstacles are also present, including public concerns about hormone use, increased standardized requirements from physicians for combination preparations, and intensified competition from alternatives such as single-agent antifungals and non-steroidal anti-inflammatory products. Furthermore, stricter regulations on hormone-containing combination preparations in some countries and regions may limit their promotion.
This report is a detailed and comprehensive analysis for global Compound Ketoconazole Cream market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Compound Ketoconazole Cream market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Compound Ketoconazole Cream market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Compound Ketoconazole Cream market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Compound Ketoconazole Cream market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Compound Ketoconazole Cream
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Compound Ketoconazole Cream market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, China Resources Sanjiu Medical & Pharmaceutical, Shanghai Baolong Pharmaceutical, Janssen Pharmaceutica (Johnson & Johnson), Chengdu Diao Pharmaceutical Group, Shanghai Pharmaceuticals Holding, Henan Lingrui Pharmaceutical, Zhejiang Dingtai Pharmaceutical, Zennova Pharma Group, Teva Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Compound Ketoconazole Cream market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Ketoconazole + Clobetasol Propionate
Ketoconazole + Dexamethasone
Ketoconazole + Hydrocortisone
Ketoconazole + Metronidazole
Others
Market segment by Drug Management Classification
Rx
OTC
Market segment by Specifications
5g
10g
15g
25g
30g
Others
Market segment by Sales Channels
Hospitals
Pharmacies
E-Commerce Platforms
Clinics
Market segment by Application
Tinea Corporis
Tinea Cruris
Tinea Manuum
Tinea Pedis
Tinea Versicolor
Cutaneous Candidiasis
Malassezia Folliculitis
Others
Major players covered
Bayer
China Resources Sanjiu Medical & Pharmaceutical
Shanghai Baolong Pharmaceutical
Janssen Pharmaceutica (Johnson & Johnson)
Chengdu Diao Pharmaceutical Group
Shanghai Pharmaceuticals Holding
Henan Lingrui Pharmaceutical
Zhejiang Dingtai Pharmaceutical
Zennova Pharma Group
Teva Pharmaceuticals
AdvaCare Pharma
Viatris
Almirall
Taro Pharmaceutical Industries
Stelon Biotech
FOUGERA PHARMACEUTICALS
DM Pharma
Vibcare Pharma
Trumac Healthcare
Gnova Biotech
Stensa Lifesciences
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Compound Ketoconazole Cream product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Compound Ketoconazole Cream, with price, sales quantity, revenue, and global market share of Compound Ketoconazole Cream from 2021 to 2026.
Chapter 3, the Compound Ketoconazole Cream competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Compound Ketoconazole Cream breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Compound Ketoconazole Cream market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Compound Ketoconazole Cream.
Chapter 14 and 15, to describe Compound Ketoconazole Cream sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Compound Ketoconazole Cream. Industry analysis & Market Report on Compound Ketoconazole Cream is a syndicated market report, published as Global Compound Ketoconazole Cream Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Compound Ketoconazole Cream market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.